Wells Fargo’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-33
| Closed | -$59 | – | 6814 |
|
2025
Q1 | $59 | Sell |
33
-567
| -95% | -$1.01K | ﹤0.01% | 5958 |
|
2024
Q4 | $1.89K | Sell |
600
-2,222
| -79% | -$7.01K | ﹤0.01% | 5691 |
|
2024
Q3 | $5.81K | Sell |
2,822
-200
| -7% | -$412 | ﹤0.01% | 5489 |
|
2024
Q2 | $4.41K | Sell |
3,022
-6,769
| -69% | -$9.88K | ﹤0.01% | 5508 |
|
2024
Q1 | $22.9K | Buy |
9,791
+737
| +8% | +$1.73K | ﹤0.01% | 5158 |
|
2023
Q4 | $18.3K | Buy |
9,054
+723
| +9% | +$1.46K | ﹤0.01% | 5233 |
|
2023
Q3 | $40.3K | Sell |
8,331
-1,983
| -19% | -$9.6K | ﹤0.01% | 4941 |
|
2023
Q2 | $70.5K | Buy |
10,314
+5,592
| +118% | +$38.2K | ﹤0.01% | 4968 |
|
2023
Q1 | $34.2K | Buy |
4,722
+3,156
| +202% | +$22.8K | ﹤0.01% | 5076 |
|
2022
Q4 | $20.1K | Sell |
1,566
-158
| -9% | -$2.03K | ﹤0.01% | 4941 |
|
2022
Q3 | $25K | Sell |
1,724
-365
| -17% | -$5.29K | ﹤0.01% | 4974 |
|
2022
Q2 | $26K | Buy |
2,089
+997
| +91% | +$12.4K | ﹤0.01% | 5042 |
|
2022
Q1 | $18K | Buy |
1,092
+298
| +38% | +$4.91K | ﹤0.01% | 5715 |
|
2021
Q4 | $19K | Buy |
794
+714
| +893% | +$17.1K | ﹤0.01% | 5840 |
|
2021
Q3 | $2K | Sell |
80
-1
| -1% | -$25 | ﹤0.01% | 6269 |
|
2021
Q2 | $2K | Hold |
81
| – | – | ﹤0.01% | 6229 |
|
2021
Q1 | $1K | Hold |
81
| – | – | ﹤0.01% | 6408 |
|
2020
Q4 | $1K | Buy |
81
+33
| +69% | +$407 | ﹤0.01% | 6044 |
|
2020
Q3 | $1K | Buy |
48
+2
| +4% | +$42 | ﹤0.01% | 5876 |
|
2020
Q2 | $1K | Buy |
46
+36
| +360% | +$783 | ﹤0.01% | 5802 |
|
2020
Q1 | $0 | Buy |
+10
| New | – | ﹤0.01% | 6481 |
|